ICD-10 Coding for Autosomal Dominant Polycystic Kidney Disease(N28.89U, Q61.19, Q61.19A)
Learn about the ICD-10 coding for autosomal dominant polycystic kidney disease (ADPKD), including documentation requirements and clinical validation criteria.
Complete code families applicable to Autosomal Dominant Polycystic Kidney Disease
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Q61.2 | Autosomal dominant polycystic kidney disease | Use when ADPKD is confirmed through genetic testing or meets clinical criteria. |
|
| Q61.3 | Polycystic kidney, unspecified | Use when documentation lacks confirmation of inheritance pattern. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAutosomal Dominant Polycystic Kidney Disease
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Autosomal Dominant Polycystic Kidney Disease.
Omitting family history in documentation
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or reduced reimbursement.
Mitigation
Always document family history for suspected genetic conditions., Use templates to ensure comprehensive documentation.
Confusing ADPKD with ARPKD
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification affects compliance with coding standards., Data Quality: Impacts accuracy of patient records and data analytics.
Mitigation
Verify inheritance pattern and age of onset to differentiate.
Using unspecified codes when specific ones apply
Impact
Reimbursement: May affect DRG assignment and reimbursement rates., Compliance: Leads to potential audit issues., Data Quality: Reduces specificity and accuracy of health data.
Mitigation
Ensure documentation supports specific coding with genetic or imaging evidence.
Genetic testing documentation
Impact
Lack of documentation for genetic testing results can lead to audit issues.
Mitigation
Ensure all genetic testing results are included in patient records.